JP2005506296A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005506296A5 JP2005506296A5 JP2002576798A JP2002576798A JP2005506296A5 JP 2005506296 A5 JP2005506296 A5 JP 2005506296A5 JP 2002576798 A JP2002576798 A JP 2002576798A JP 2002576798 A JP2002576798 A JP 2002576798A JP 2005506296 A5 JP2005506296 A5 JP 2005506296A5
- Authority
- JP
- Japan
- Prior art keywords
- channel
- type
- inactivating
- slowly
- activity indicating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000694 effects Effects 0.000 claims 3
- 206010020853 Hypertonic bladder Diseases 0.000 claims 2
- 208000009722 Overactive Urinary Bladder Diseases 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 230000009849 deactivation Effects 0.000 claims 2
- 208000020629 overactive bladder Diseases 0.000 claims 2
- -1 [1] benzothiepin-9-yl Chemical group 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000002779 inactivation Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27969801P | 2001-03-30 | 2001-03-30 | |
| PCT/US2002/009577 WO2002078523A2 (en) | 2001-03-30 | 2002-03-29 | Agent for the treatment of overactive bladder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005506296A JP2005506296A (ja) | 2005-03-03 |
| JP2005506296A5 true JP2005506296A5 (enExample) | 2005-12-22 |
Family
ID=23070051
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002576798A Pending JP2005506296A (ja) | 2001-03-30 | 2002-03-29 | 過活動膀胱治療剤 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1372630A4 (enExample) |
| JP (1) | JP2005506296A (enExample) |
| CA (1) | CA2442437A1 (enExample) |
| WO (1) | WO2002078523A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2388898B (en) * | 2002-04-02 | 2005-10-05 | Inverness Medical Ltd | Integrated sample testing meter |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT979821E (pt) * | 1997-04-15 | 2007-01-31 | Kyowa Hakko Kogyo Kk | Compostos triciclicos |
-
2002
- 2002-03-29 JP JP2002576798A patent/JP2005506296A/ja active Pending
- 2002-03-29 EP EP02728597A patent/EP1372630A4/en not_active Withdrawn
- 2002-03-29 CA CA002442437A patent/CA2442437A1/en not_active Abandoned
- 2002-03-29 WO PCT/US2002/009577 patent/WO2002078523A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006098918A3 (en) | Substituted gamma lactams as therapeutic agents | |
| DE60237145D1 (de) | Chinazolinderivate | |
| EA200100678A1 (ru) | N-уреидоалкил-пиперидины в качестве модуляторов активности рецепторов хемокинов | |
| TWI328576B (en) | Diketohydrazine derivative compound, medicament containing same as active ingredient | |
| RU2003135482A (ru) | Геропротектор на основе гидрированных пиридо(4,3-b) индолов (варианты), фармакологическое средство на его основе и способ его применения | |
| MXPA02012712A (es) | N-ureidoheterocicloalquil-piperidinas como moduladores de la actividad del receptor de quimiocinas. | |
| WO2003024401A3 (en) | Piperizinones as modulators of chemokine receptor activity | |
| NO20045486L (no) | Nye forbindelser og deres anvendelse | |
| BRPI0417714A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| NO20041059L (no) | Kombinasjon av utvalgte opioder med muskarinantagonister for behandling av urininkontinens | |
| DE60302157D1 (de) | Opioidrezeptorantagonisten | |
| CA2386793A1 (en) | New selective retinoid agonists | |
| SE0002729D0 (sv) | Novel compound form | |
| JP2004529133A5 (enExample) | ||
| SE9702066L (sv) | Nytt salt | |
| JP2005506296A5 (enExample) | ||
| WO2006064228A3 (en) | Thiazolopyramidine compounds for the modulation of chemokine receptor activity | |
| WO2002078633A3 (en) | Agent for the treatment of bladder irritative symptoms accompanied by benign prostatic hyperplasia | |
| DE602004022783D1 (de) | Heterozyklische harnstoff-derivate für die behandlung von schmerzen. | |
| NO20070421L (no) | Radiosensitiviserende middel | |
| WO2005048932A3 (en) | N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity | |
| HUP0301906D0 (en) | Use of bicyclo[2.2.1]heptane derivatives for producing of pharmaceutical compositions having neuroprotectiv activity | |
| AU2003266607A1 (en) | Therapeutic agent for rheumatism containing benzamide derivative as active ingredient | |
| ATE491709T1 (de) | Pyrrolidinohydrochinazoline | |
| WO2002078523A3 (en) | Agent for the treatment of overactive bladder |